Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OmniSonics, Boston work on stroke tech together

This article was originally published in Clinica

Executive Summary

Vascular disease firm OmniSonics Medical Technologies (Wilmington, Massachusetts) is set to jointly develop its OmniWave technology alongside Boston Scientific for an application in the treatment of acute ischaemic stroke. The OmniWave product is designed to deliver low-power ultrasonic energy to remove a blood clot. Funding of the project, based on the achievement of certain development milestones, will come from Boston, which also has the option to acquire the resulting technology and the exclusive rights to the intellectual property covering the treatment of acute stroke. Other financial details of the licensing and development agreement were not disclosed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042799

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel